Søg i kliniske forsøg efter: IMC-001,IMC-001-202,TMB-H
I alt 1 resultater
-
ImmuneOncia Therapeutics Inc.Ikke rekrutterer endnuTMB-H | Histologisk eller cytologisk bevist metastaserende eller lokalt avancerede solide tumorer
Denne side blev automatisk oversat, og nøjagtigheden af oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.
Sponsorer og samarbejdspartnere
- CARITAS Rundum zu Hause betreut
- Sichuan Haisco Pharmaceutical Group Co., Ltd
- Yancheng City NO.1 People's Hospital
- EMET Pharmaceuticals, LLC
- Grünenthal Denmark ApS
- Axon Neuroscience SE
- Irish Endocrine Society
- Department of Anesthesiology, North Denmark Regional Hospital
- Eastman Kodak Company
- YASEMİN AYDIN KARTAL
- Alessandra Palo
- Aga Khan Foundation, Pakistan
- Doterra Healing Hands Foundation
- Gregorio Covino
- Outpatient Endovascular and Interventional Society
- Erzurum Regional Training & Research Hospital
- Phramongkutklao College of Medicine and Hospital
- Saint Pierre Institute - Palavas les Flots
- CeRSM
- Invicta Medical Inc.
- Se den fulde liste
Medicinske tilstande
- Canaloplastik
- Fibromyoma;Cervix
- Refraktær ondartet hudneoplasma
- Dokumenteret tavs iskæmi
- MEK-hæmmer-associeret serøs retinopati
- Kræft i læbe og mundhule
- Corticobasal degeneration
- Voksen Myxopapillær Ependymom
- Contingent Versus Noncontingent Incentives
- B-celle Akut Lymfoblastisk Leukæmi
- Skulderarthropati
- Desquamative Interstitiel Pneumoni
- Retroperitoneal sygdom
- Hostevariant astma
- Blodprøvetagning
- Aktive kokainbrugere
- Dyrestøttet intervention
- Ledplastik
- Kemoterapi-induceret febril neutropeni (FN)
- Etomidate Overdosering af ubestemt hensigt
- Se den fulde liste
Narkotikainterventioner
- LY2216684
- Systemic intravenous lidocaine infusion
- Konsolidering (intensive og ikke-intensive veje) - behandling med bortezomib, cyclophosphamid og dexamethason (VCD)
- Lenalidomid
- Risperidon
- Betamethason
- Carbetocin
- Enteral iltbehandling
- Leuprolidacetat 11,25 mg
- Amantadinsulfat
- Pregabalin
- Anti-PD1 antistof, nimotuzumab og capecitabin
- Pacritinib
- MYL-1501D produkt ved hjælp af fremstillingsproces VI
- Neridronat
- Naltrexon 50 mg + inaktiv marihuana (0% THC)
- Test lak
- Niraparib
- Ranitidin
- Apatinib
- Se den fulde liste
CROs by country
- Contract Research Organizations in Belarus
- Contract Research Organizations in Cameroon
- Contract Research Organizations in Colombia
- Contract Research Organizations in Czech Republic
- Contract Research Organizations in Indonesia
- Contract Research Organizations in Iran
- Contract Research Organizations in Jordan
- Contract Research Organizations in Mauritania
- Contract Research Organizations in Oman
- Contract Research Organizations in Portugal
- Contract Research Organizations in Turkmenistan
- Contract Research Organizations in Uruguay
- Contract Research Organizations in Uzbekistan
- CRO list by country